pasted image 0Do Your LifeSci Advisors Homework: Five Things to Know About Sell Side Research Coverage

Many businesses see sell side research coverage as an obligatory fee on the bill each month. Sell side research has many opportunities to offer past the topical stock reports. By fully understanding your sell side research team, you can gain the most from our services.

Equity Research Definitions

We understand that our reports are full of investor jargon. These terms can quickly become confusing, and learning the terms can be as difficult as learning a new language. There’s a few definitions we need can establish so you can fully understand what sell side research is.

●         Equity research. Equity research is the study of a small bundle of stocks. By studying the activity patterns of the stocks, equity research analysts can recommend sound investment decisions for both professional investors and, increasingly, the public. Their research is demonstrated by reports that place Buy, Sell, or Hold ratings on covered companies.

●         Equity research coverage. A “covered” company is one that is included and rated in an equity research report. Analysts often become experts of the industry in order to make educated and complete investment recommendation, so many equity research teams opt to focus on one specific area. Life science advisors focus on lifesci research companies, ranging from pharmaceutical research to cochlear implant research, cell therapy, stent research, and more.

●         Sell side research. Sell ride equity research is opposed to buy side research. Sell side research focuses on covered companies and produces stock reports and recommendations. Buy side research uses research on individual companies to offer private recommendations to fund managers to offer the highest risk adjusted return on investment.

Why Do I Need Sell Side Research Coverage?


Getting focus and attention from investors is one of the most difficult parts of getting a life science research company rolling. No matter how many skilled scientists you have on your team, little to nothing can get done without the proper funds.

By partnering with life science advisors, you can get your company in front of both professional investors and the public. Our sell side research analyses can help attract investors to your company. Our research is the direct conduit to a large audience of investors waiting for a company like yours to come along.

1. Communication Is Key

pasted image 0 1

Our analysts are experts on your business’s stocks and the industry surrounding it. Without the right communication, however, we may not fully understand the foundation and fundamentals of your company. With this miscommunication, your analyst may not fully understand the positives and possibilities of your company. This can lead to downgraded stocks that never reach the target price. Equity research isn’t a “one and done” contract. Consistent communication between companies and the research team is a great way to achieve the best analyses.

After you set up your sell side research coverage, be sure to speak to our analysts to explain the foundations of your strategy for growth and your business model.

2. Sell Side Research Makes a Difference

Millionaire private investors aren’t the only audience for our sell side reports. Unlike buy side research, sell side research is open to the public. This way, the layman with a side venture in small-time investments can see and respond to our reports. Don’t count out the power behind many small investments! They can often come to overpower individual large investments made by professional investors.

Sell side research has an impact on stocks in the short-term. Investors (especially nonprofessionals) place a lot of trust in sell side equity research. Don’t count out sell side research as just another business expense. The proper relationship and communication with your equity research analyst team can lead to huge success.

3. Analyst Ratings Can Be Negative, But They Can Change

pasted image 0 2

Getting back a downgraded rating on a report can be an awful feeling. We’ve been there. We understand how difficult it can be, but it’s not the analyst’s fault. Unforeseen circumstances and situations out of your control can lead to a stock downgrade. It’s not necessarily the fault of your business or something you did incorrectly.

Analysts are people too, and we’re an important part of the team leading your business to success. Finger pointing and assigning blame for a downgraded stock can cause tension. A strained relationship between your company and our analysts is inevitably negative. This results in faulty communication, possibly leading to further downgrading.

If your stock gets downgraded, try to address it as the need for more open communication. Work to better educate your analyst on your company’s foundation and business models. With a positive attitude and open communication, you have a much better chance of getting to your target price.

4. Sell Side Researchers Offer More Than Just Stock Reports

Being a sell side researcher means that our analysts are experts in your industry. While this is crucial for understanding your company’s place in the industry and its potential, it’s also helpful for ascertaining how the industry sees your company.

Talk to your analyst about how other companies in the industry see your business. Does the industry seem to be headed in a specific direction? How can your business capitalize on the new focus of the industry? What opinions do the investment community have about your business? Are you well respected, or are investors skeptical about your success?

Your analyst is your partner in success. Capitalize on their knowledge of the industry to get the most out of your sell side research coverage.

5. Each Analyst Has Unique Strengths

Your report isn’t written by a robot cranking out numbers. It’s important to remember that behind every report, there’s a person investigating your company. Each analyst has unique skills and network connections. Some analysts excel at establishing institutional relationships that can benefit your company; others may be focused on the scope at which their reports get distributed.

By talking to your equity research team, you can expand on your analyst’s strengths. Involving your analyst as a team member rather than an employee can lead to new opportunities and improved connections.

List of Top Biotechnology Companies

biotech 647 123115115942

Biotechnology is a word you may have heard thrown around in conversation as of late. That’s because it’s a newer industry that is making waves and revolutionizing biological science. Biotechnology is defined as the manipulation of living organisms (or components thereof) to produce commercially beneficial products. Biotech methods can be a bit controversial since the sciences and technologies are so new, but reliable and important products such as pest-resistant crops, new strains of bacteria and breakthrough pharmaceutical drugs have all come out of biotech research.

Biotech is generally traced back to the Stanford lab in the 1970s when Boyer and Cohen demonstrated DNA cloning. Now, biotechnology has become a huge industry that is making strides in the biological field and solving modern-day problems left and right. Today, the main two markets of biotechnology are agricultural and medical. These cutting-edge methods the biotech field uses have attracted droves of entrepreneurs to create startups in the biotechnology field. These startups have grown since inception, and today, there are hundreds of biotechnology companies that have made a huge splash and have become important and profitable research corporations providing services to the big dogs of medicine and agriculture.

The future is bright for these biotechnology companies, and more and more industries are looking to use their revolutionary research and findings to progress our society and hopefully solve problems we thought were unsolvable. Let’s take a look at the biggest, best, and most profitable biotech research companies out there today.

Top US Biotech Companies

The United States has quite the hold on the biotech market. It has the largest market for biotech pharmaceuticals and includes about a third of the world’s top biotech research companies. Let’s take a look at some of the top players the US has in the biotech arena.

1. Amgen

amgen pharma CONTENT 2017

Based out of Thousand Oaks, California, Amgen is focused on new medicines and human therapeutics. They work to create new solutions in molecular and cellular biology, with some of their biggest products honing in on cancer care, inflammation, and nephrology, or kidney care.

2. Gilead

t i xu ng

Gilead focuses their work on HIV/AIDS, liver diseases, cardiovascular conditions and respiratory conditions. Headquartered in California, Gilead has helped claim a lot of firsts for the Golden State. Gilead has produced firsts such as a complete HIV/AIDS treatment, just for starters.

3. Celgene

Celgene, based out of New Jersey, has dedicated itself to coming up with new solutions for cancer and inflammatory disorders. Their claim to fame is a product called Revlimid, which treats multiple myeloma patients.

4. Biogen

Biogen is dedicated to creating solutions to neurodegenerative, hematologic, and autoimmune diseases. They focus on the research, development, and delivery of therapies for such diseases. Based in Cambridge, Massachusetts, they want to find ways to treat diseases through gene therapy and RNA medicines.

5. Regeneron

Regeneron is headquartered in New Jersey along with Celgene.  Founded in 1988, the company was founded with the intent to focus on neuropathic factors (a type of biomolecule) and their regenerative benefits. Since then, it has expanded its concentration to include and tyrosine and cytokine kinase receptors.


Top International Biotech Companies

Biotech companies have been spreading like wildfire and there is now a strong biotech presence in many countries throughout Europe and Asia, especially. Let’s explore some of the international companies in the industry.

  1. Rosche

roche stories 2014 05 27 1

Roche calls itself the largest biotech company in the world. They currently have 14 pharmaceutical drugs on the market and are still developing more. They have maintained their position at the forefront of cancer research and care. They’ve had several breakthrough products in neuroscience and opthamology as well.

     2.  Novo Nordisk

A multinational corporation, Novo Nordisk has facilities, offices, or other locations in seven different countries. Novo Nordisk is based in Denmark, however. They’ve kept their primary focus on hemophilia, diabetes, hormone replacement and growth hormone therapy.

 A Growing Industry

Since its inception, biotechnology has been a growing industry that has more to offer as the years go by and technology becomes more and more advanced. The promise is so high, in fact, that in some regions, states, or cities, biotech has become a focal point of the area’s economic development plan.

Going into biotech requires two key things from any company:

1. The ability to perform strong and in-depth research

2. The ability to turn that research into deliverables for commercial sale

If you’ve thought about starting up a biotech company but aren’t sure how to get your foot in the door, contact a lifesci advisors today for guidance on investor relations and communications.

Lifesci Advisors Blog

Dayton, Ohio


(937) 898-1589

OHIO, USA- Developed in March of 2018, Lifesci Advisors has quickly become a unique and invaluable resource for those in the life science and life science advising fields.

Their team of professionals have many years in the field of life science advising combined between them, and they have dedicated their time and expertise to helping others in the field learn about and understand the best tools and methods to use when it comes to life science advisory.

Although young, Lifescience Advisors Blog has already published posts that provide insight from people who know the industry best, and now, with their new and improved website, they can provide even more information to their readers.

For those who work in the life science industry, finding a trusted advisor is an aspect of the career that is often overlooked, but shouldn’t be. Due to the nature of life sciences, it is important to employ an advisor that will help find funding for one’s business.

Life Science Advisors blog has posts on the aspect of life science investor relations, as well as other oft-overlooked business aspects of life science careers such as equity research, and capital markets solutions. Understanding these aspects of the life science career path is crucial to a successful business, and Lifesci Advisors Blog’s new website lays it all out in a way that is palatable and easy to navigate, and it is revolutionizing the field.

Whatever the area of life sciences that their readers are involved in, Life Science Advisors provide the information that is pertinent to running a successful life science business. They are experts in investor relations, one of the most important parts of running a life science business, and are familiar with helping clients find good investors for their business no matter which life science field they are in. Their new website launch includes information about biotech investor relations, and many other important aspects of life science businesses.

With their new website launch, Lifesci Advisors Blog is able to have an even greater reach and impact in the life science community at large. Although new to the business, their blog is already informative and impactful, and will only continue to grow with the introduction of their new website. Readers have quickly come to trust Lifesci Advisors Blog to help them better understand the ins and outs of the life science industry, and their new website makes it that much easier to understand.

Contact Name: Anthony T. Jensen